80 likes | 196 Views
Phase 2. Liver Transplantation. Treatment Naïve and Treatment Experienced. 3D + RBV in Liver Transplant Recipients with Recurrent HCV GT1 Study M12-999. Kwo P, et al. 49 th EASL. April 2014. Abstract O114.
E N D
Phase 2 Liver Transplantation Treatment Naïve and Treatment Experienced 3D + RBV in Liver Transplant Recipients with Recurrent HCV GT1Study M12-999 Kwo P, et al. 49th EASL. April 2014. Abstract O114.
3D + RBV in Liver Transplant Recipients with Recurrent HCV GT1Study M12-999: Study Design Source: Kwo P, et al. 49th EASL. April 2014. Abstract O114.
3D + RBV in Liver Transplant Recipients with Recurrent HCV GT1Study M12-999: Regimen 0 24 36 Week 3D + Ribavirin N = 34 SVR12 3D =Paritaprevir-Ritonavir-Ombitasvir + Dasabuvir Drug Dosing3D = Paritaprevir-Ritonavir-Ombitasvir (150/100/25 mg once daily)+ Dasabuvir: 250 mg twice dailyRibavirin (RBV): dosing managed per investigator discretion; most patients received 600-800 mg/day Source: Kwo P, et al. 49th EASL. April 2014. Abstract O114.
3D + RBV in Liver Transplant Recipients with Recurrent HCV GT1Study M12-999: Baseline Characteristics Source: Kwo P, et al. 49th EASL. April 2014. Abstract O114.
3D + RBV in Liver Transplant Recipients with Recurrent HCV GT1Study M12-999: Results 34/34 34/34 32/33 25/26 RVR = rapid virologic response; EOTR = end of treatment response; SVR = sustained virologic response Source: Kwo P, et al. 49th EASL. April 2014. Abstract O114.
3D + RBV in Liver Transplant Recipients with Recurrent HCV GT1Study M12-999: Adverse Events Source: Kwo P, et al. 49th EASL. April 2014. Abstract O114.
3D + RBV in Liver Transplant Recipients with Recurrent HCV GT1Study M12-999: Conclusions Note: ABT-450/r = Paritaprevir-Ritonavir Source: Kwo P, et al. 49th EASL. April 2014. Abstract O114.
This slide deck is from the University of Washington’s Hepatitis C Online and Hepatitis Web Study projects. Hepatitis C Onlinewww.hepatitisc.uw.edu Hepatitis Web Studyhttp://depts.washington.edu/hepstudy/ Funded by a grant from the Centers for Disease Control and Prevention.